期刊文献+

Crystal Structure and Characterization of Salicylic Acid-benzene Azimide Cocrystal 被引量:1

Crystal Structure and Characterization of Salicylic Acid-benzene Azimide Cocrystal
下载PDF
导出
摘要 A new single crystal of 1:1 salicylic acid-benzene azimide was determined and cha-racterized. It belongs to space group P21/n with a = 13.8085(13), b = 5.3846(4), c = 16.7063(13) A and β = 102.331(9)°. Crystals of the title compound, C7H6O3·C6H5N3, were obtained by cocrys- tallization. FT-IR, Raman spectroscopy and TGA-DTA were applied to characterize the title compound as supplemental evidence to prove the formation of the crystal. Our work describes the solubility of the crystal by considering the equilibria between the crystal, components, and solution mixture. A new single crystal of 1:1 salicylic acid-benzene azimide was determined and cha-racterized. It belongs to space group P21/n with a = 13.8085(13), b = 5.3846(4), c = 16.7063(13) A and β = 102.331(9)°. Crystals of the title compound, C7H6O3·C6H5N3, were obtained by cocrys- tallization. FT-IR, Raman spectroscopy and TGA-DTA were applied to characterize the title compound as supplemental evidence to prove the formation of the crystal. Our work describes the solubility of the crystal by considering the equilibria between the crystal, components, and solution mixture.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2013年第2期289-295,共7页 结构化学(英文)
基金 Supported by Sichuan Provincial Key Scientific and Technological Project (No. 05SG011-021-2)
关键词 salicylic acid benzene azimide COCRYSTAL hydrogen bonds SOLUBILITY salicylic acid, benzene azimide, cocrystal, hydrogen bonds, solubility
  • 相关文献

参考文献16

  • 1Steiner, T. Competition of hydrogen-bond acceptors for the strong carboxyl donor. Acta Crystallogr. B 2001, 57,103-106.
  • 2Vangala, V. R.; Bhogala, B. R.; Dey, A. Correspondence between molecular functionality and crystal structures. Supramolecular chemistry of a family of homologated aminophenols. J. Am. Chem. Soc. 2003, 125, 14495-14509.
  • 3Vishweshw, A. R. P.; Nangia, A.; Lynch, V. M. Supramolecular synthons in phenol-isonicotinamide adducts. Cryst. Eng. Comm. 2003, 5, 164-168.
  • 4Remenar, J. F.; Morissette, S. L.; Peterson, M. L. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125, 8456-8457.
  • 5Walsh, R. D. B.; Bradner, M. W.; Fleischman, S. G; Morales, L. A.; Moulton, B. Crystal engineering of the composition of pharmaceutical phases. Chem. Commun. 2003, 2, 186—187.
  • 6Fleischman, S. G; Kuduva, S. S.; McMahon, J. A.; Moulton, B.; Walsh, R. D. B.; Rodriguez-Homedo, N. Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine. Cryst. Growth & Des. 2003, 3, 909—919.
  • 7McMahon, J. A.; Bis, J. A.; Vishweshwar, P.; Shattock, T. R.; McLaughlin, O. L.; Zaworotko, M. J. Crystal engineering of the composition of pharmaceutical phases. 3. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals. Zeitschrift. Fur. Kristallographie 2005,220, 340-350.
  • 8Bingham, A. L.; Hughes, D. S.; Hursthouse, M. B.; Lancaster, R. W.; Tavener, S. Over one hundred solvates of sulfathiazole. Chem. Commun. 2001, 7, 603-604.
  • 9Stahl, P. H. ; Wermuth, C. G Handbook of pharmaceutical salts: properties, selection, and use. Third Ed., Thoumas, K. New York 2005.
  • 10Berge, S. M.; Bighley, L. D.; Monkhouse, D. C. Pharmaceutical salts. J. Pharm Sci. 1977, 66, 1-19.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部